Skip to main content

REVIEW article

Front. Immunol.
Sec. Viral Immunology
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1433531

Obesity-associated Compromised Immunity in Post-COVID-19 Distress: A Critical Control Point of Chronicity

Provisionally accepted
  • Pusan National University, Busan, Republic of Korea

The final, formatted version of the article will be published soon.

    Post-COVID-19 syndrome is recognized as a multifactorial disorder, with persistent presence of viral antigens, discordant immunity, delayed viral clearance, and chronic inflammation. Obesity has emerged as an independent risk factor for both SARS-CoV-2 infection and its subsequent sequelae. In this study, we aimed to predict the molecular mechanisms linking obesity and post-COVID-19 distress. Viral antigen-exposed adipose tissues display remarkable levels of viral receptors, facilitating viral entry, deposition, and chronic release of inflammatory mediators and cells in patients. Subsequently, obesity-associated inflammatory insults are predicted to disturb cellular and humoral immunity by triggering abnormal cell differentiation and lymphocyte exhaustion. In particular, the decline in SARS-CoV-2 antibody titers and T-cell exhaustion due to chronic inflammation may account for delayed virus clearance and persistent activation of inflammatory responses. Taken together, obesity-associated defective immunity is a critical control point of intervention against post-COVID-19 progression, particularly in subjects with chronic metabolic distress.Established risk factors for SARS-CoV-2 infection include advanced age, diabetes, and metabolic syndrome (1). Obesity has been associated with an increased risk of SARS-CoV-2 infection, as well as an increased likelihood of needing intensive care and invasive mechanical ventilation. Obesity emerged as the predominant comorbidity among healthcare workers who were hospitalized in 14 US states, as reported by the COVID-19-associated Hospitalization Surveillance Network (2). Obesity has been recognized as an independent risk factor for the onset of . Although there appears to be a non-linear correlation between body mass index (BMI) and the severity of COVID-19 (4), multiple studies have indicated that individuals with a BMI over 25 kg/m2 experienced

    Keywords: COVID-19, SARS-CoV-2, post COVID-19 syndrome, Obesity, Immunity, ACE2

    Received: 16 May 2024; Accepted: 25 Jul 2024.

    Copyright: © 2024 Jang and Moon. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Yuseok Moon, Pusan National University, Busan, Republic of Korea

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.